CClinicalTrials.gg
CompletedNCT04532658TopSurgeonsUpdated Jul 11, 2025

Evaluation of Coaching Impact on Surgical Outcomes

An interventional study of Coaching program in Surgery, sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2025-07-11.

Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled Feb 2019, registered Aug 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
20,791
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Study summary

This two arms parallel cluster-randomized trial will evaluate the impact of a customized coaching program for surgeons on the occurrence of patient major adverse events. Trends in surgical outcomes before and after the intervention will be compared between surgeons randomly assigned to the coaching program against non-exposed surgeons.

02

Conditions studied

  • Surgery
03

In context

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All adults needing a surgery who are operated by one of the participating surgeons

Exclusion criteria

Exclusion Criteria:

  • Age \< 18 years old
  • Absence of surgical procedure
  • Palliative care
  • Organ transplantation
  • Refusal for personal data sharing
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
20,791 participants (actual)

Study arms

  • Experimental
    Intervention arm

    Surgeons randomly assigned to the intervention arm

    Behavioral: Coaching program

  • No intervention
    Control arm

    Surgeons randomly assigned to the control arm

Interventions

  • BehavioralCoaching program

    * Charting system for outcomes feedback * Profiling of individual surgeon * Modules of improvement

06

What researchers measure

Primary outcomes

  1. Occurrence of major adverse event

    Time frame: During surgery or within 30 days after the operation

  2. Occurrence of death

    Time frame: During surgery or within 30 days after the operation

  3. Occurrence of unplanned stay in critical/intensive care unit

    Time frame: Within 30 days after the operation

  4. Occurrence of unplanned reoperation

    Time frame: Within 30 days after the operation

  5. Occurrence of intraoperative and postoperative complications

    Time frame: During surgery or within 30 days after the operation

  6. : Occurrence of avoidable hospital readmission for complication

    Time frame: Within 30 days after the operation

  7. Operative time

    Time frame: From skin incision to wound closure

  8. Length of stay

    Time frame: From hospital admission to discharge, within 30 days after operation

  9. Hospitalization costs

    Time frame: Within 30 days after the operation

  10. Surgeon well-being

    Time frame: Throughout the study, Through study completion, an average of 1 year

07

Study locations

1 site
  • Hospices Civils de Lyon
    Lyon, France
08

References and documents

Related links

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04532658
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Aug 31, 2020
Start date
Feb 1, 2019
Primary completion
Jan 31, 2024
Completion
Jan 31, 2025
Last update
Jul 11, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion